Related by context. All words. (Click for frequent words.) 65 TEAEs 64 severe neutropenia 62 generalized edema 62 PREZISTA r arm 61 receiving ISENTRESS 61 severe hypoglycemic 61 REYATAZ r arm 61 hematological adverse 60 Infusion Reactions Severe 60 â ‰ ¥ 60 neutropenia dehydration dyspnea 60 intracerebral hemorrhages 60 prolonged QT interval 59 seropositive patients 59 arterial thromboembolic events 59 achieved ACR# 59 hypoglycemic episodes 59 hematologic adverse 59 del 5q MDS 59 aged ≥ 59 Treatment emergent adverse 59 Erythropoietic therapies may 59 demyelinating 59 hypophosphatemia 59 mcg albinterferon alfa 2b 58 hemorrhagic cystitis 58 oxycodone CR 58 hypoglycemic events 58 ≥ Grade 58 severe exacerbations 58 herpes zoster shingles 58 lopinavir r arm 58 RAPTIVA 58 pyrexia mucositis sepsis febrile 58 apnea hypopnea 58 ALT flares 58 neurologic complications 58 COPD exacerbation 58 DLTs 58 laboratory abnormalities 58 hypoglycaemic episodes 58 mcg doses 58 macrovascular events 58 recurrent VTE 58 octreotide LAR 58 generalized tonic clonic seizures 58 definite stent thrombosis 58 RLAI 58 ARCOXIA 58 oral hypoglycemic agents 58 URTI 58 neutropenia febrile neutropenia 57 microgram kg 57 insulin detemir 57 dapagliflozin plus 57 baseline HbA1c 57 nadroparin 57 elevated triglyceride levels 57 adjunctive placebo 57 pooled comparator 57 glycated hemoglobin levels 57 proctitis 57 NNT = 57 VIIBRYD 57 EXJADE 57 cerebrovascular events 57 thromboembolic 57 diabetes dyslipidemia 57 heFH 57 discontinuations due 57 mg q8h 57 unresectable HCC 57 Exacerbations 57 incontinence episodes 57 episodic migraine 57 ipsilateral stroke 57 achieved CCyR 57 virologic failure 57 acarbose 57 diarrhea nausea fatigue 57 Febrile neutropenia 57 Recurrences 57 variceal bleeding 57 nasopharyngitis upper 56 #mg/day [002] 56 headache abdominal pain 56 DETROL LA 56 T2DM 56 chills fever headache 56 cerebrovascular accidents 56 CIMZIA TM 56 MCyR 56 serum aminotransferase levels 56 NovoLog ® Mix 56 ziprasidone Geodon 56 rizatriptan 56 severe hypoglycaemia 56 neutropenia thrombocytopenia 56 Hypotension 56 COPD exacerbations 56 ALT elevation 56 necrotizing pancreatitis 56 NPH insulin 56 Allergic Rhinitis 56 MADRS score 56 insulin degludec 56 extrapyramidal symptoms 56 treatment emergent adverse 56 metastatic carcinoid tumors 56 recurrent ischemic stroke 56 interstitial pneumonia 56 myocardial infarction ventricular fibrillation 56 Postoperative complications 56 CI #.#-#.# [001] 56 sensory neuropathy 56 recurrent genital herpes 56 syncopal 56 diabetes mellitus DM 56 Hypoglycemia 56 leukopenia 56 hematologic toxicity 56 β blockers 56 intravitreal injections 56 constipation nausea 56 PRADAXA #mg 56 glyburide 56 SGPT 56 ug kg 56 gastrointestinal adverse reactions 55 transaminase elevations 55 invasive aspergillosis 55 hyperglycaemia 55 haematologic 55 mg simvastatin 55 Peginterferon Alfa 2a 55 nonvertebral fractures 55 events SAEs 55 adrenal insufficiency 55 somnolence dizziness 55 severe hypoglycemia 55 macroalbuminuria 55 CIMZIA ™ 55 peripheral sensory neuropathy 55 homozygous familial hypercholesterolemia 55 PSVT 55 HeFH 55 Angioedema 55 solifenacin 55 dizziness nausea diarrhea 55 recurrent coronary 55 adjunctive ABILIFY 55 8mg/kg 55 corticosteroid dose 55 venous thromboembolic events 55 abacavir Ziagen 55 -#.# mg dL [002] 55 recurrent wheezing 55 Newly Diagnosed Multiple Myeloma 55 salmeterol fluticasone 55 ibandronate 55 JANUMET 55 % CI #.#-#.# [007] 55 asthma exacerbation 55 alemtuzumab treated 55 FluCAM arm 55 virologic breakthrough 55 NATRECOR R 55 Toxicities 55 Serious Adverse Events 55 leucopenia 55 hypokalemia 55 HbA 1c 55 SJIA 55 nondiabetic patients 55 tipranavir r 55 NMDA receptor antagonists 55 anemia neutropenia 55 Stent thrombosis 55 elevated ALT 55 neuropsychiatric adverse 55 tolvaptan 55 spontaneous preterm birth 55 CrCl 55 + PH# 55 gout flares 55 Community Acquired Pneumonia 55 biphasic insulin aspart 55 HIV HCV coinfected 55 polyp recurrence 55 thrombotic events 55 APTIVUS r 55 mL/min/#.# m 2 55 HbA 1c levels 55 ADPKD 55 potassium sparing diuretics 55 Hemophilia B 55 FASLODEX 55 Lymphocytic 55 Byetta exenatide 55 mm Hg diastolic 55 x ULN 55 fatal anaphylactic 55 elevated fasting glucose 55 myocardial infarctions 55 Interferon Beta 55 CHD CVD 54 hemorrhagic complications 54 nontraumatic 54 OADs 54 highly emetogenic 54 Insulin Glargine 54 fasting plasma glucose 54 lispro 54 reinfarction 54 Major depressive disorder 54 nonfatal cardiovascular 54 oral antidiabetic medication 54 febrile neutropenia 54 Glimepiride 54 concomitant medications 54 diabetes mellitus T2DM 54 venlafaxine Effexor 54 VT VF 54 Venous thromboembolism 54 hyperprolactinemia 54 Lupuzor ™ 54 moderately emetogenic 54 Thrombocytopenia 54 salmeterol fluticasone propionate 54 ATACAND 54 serologically active patients 54 elevated lipase 54 mmHg diastolic 54 acute gout flares 54 4mg/kg 54 inhospital 54 interferon beta 1b 54 baseline serum creatinine 54 ocular adverse 54 recurrent UTI 54 deep venous thromboses 54 Major Depressive Disorder 54 atherogenic dyslipidemia 54 Ramipril 54 serum urate 54 alanine aminotransferase 54 headache nausea diarrhea 54 Non Alcoholic Steatohepatitis 54 SSRI SNRI 54 Telithromycin 54 recurrent venous thromboembolism 54 Leukemias 54 torsade de pointes 54 #mg/dl 54 susceptible isolates 54 cilostazol 54 Subtype 54 varicella infection 54 linaclotide treated 54 atrophic gastritis 54 neutropaenia 54 atherothrombotic disease 54 receiving XGEVA 54 endometrial hyperplasia 54 Lamictal XR 54 PAOD 54 Parnate 54 food induced anaphylaxis 54 H2 receptor antagonists 54 ADHF 54 ‰ ¥ 54 IBS C 54 Divalproex Sodium 54 hepatorenal syndrome 54 Tardive dyskinesia 54 recurrent stroke 54 dosing cohort 54 Hepatotoxicity 54 multivariable adjusted 54 Impaired glucose tolerance 54 Heavy menstrual bleeding 54 p = NS 54 retinal vein occlusion 54 Depressive disorders 54 diarrhea nausea vomiting 54 noncardiovascular mortality 54 mild renal insufficiency 54 lumiracoxib 54 Adenomas 54 hepatic failure 54 nonfatal MI 54 nocturnal hypoglycemia 54 biologic DMARD 54 ALT elevations 54 advanced adenoma 54 Arch Intern Med 54 improves glycemic 54 IIIa inhibitors 54 corticosteroid therapy 54 Polycystic ovary syndrome PCOS 54 thrombocytopenia neutropenia 54 severe hypersensitivity reactions 53 AZOR 53 FROVA 53 myopathy rhabdomyolysis 53 symptomatic hyponatremia 53 symptomatic hypotension 53 syncope fainting 53 thromboembolic events 53 ARCALYST ® 53 salmeterol HFA MDI 53 Deep vein thrombosis 53 nonobese 53 metformin sulfonylurea 53 elevated creatinine 53 gastrointestinal bleeds 53 NovoMix ® 53 Anaphylactic reactions 53 Hepatitis C Genotype 53 detemir 53 reflux disease GERD 53 overt nephropathy 53 collagenous colitis 53 CVD mortality 53 antidiabetic medication 53 nighttime awakenings 53 HPA axis suppression 53 International Prognostic Scoring 53 intensive statin therapy 53 acute febrile 53 gastrointestinal perforation 53 ARB telmisartan 53 Pioglitazone 53 CP CPPS 53 Serious adverse reactions 53 MARINOL R 53 Myalgia 53 #.#mg/dL 53 tumor lysis syndrome 53 Severe cutaneous 53 hypomagnesemia 53 dyslipidaemia 53 cerebrovascular accident 53 serum IGF 53 zolmitriptan 53 haloperidol Haldol 53 mg p = 53 vWD 53 proliferative diabetic retinopathy 53 FOLPI 53 hypercalcemia 53 serum potassium 53 Betaferon R 53 acute decompensation 53 systemic corticosteroid 53 Viread Emtriva 53 QTcF 53 moderate renal impairment 53 Pancreatic neuroendocrine tumors 53 subsyndromal 53 anemia hemoglobin 53 malignant neoplasm 53 ACE Inhibitors 53 anagrelide 53 receiving golimumab 53 lipid abnormalities 53 dalteparin 53 Clostridium difficile Infection 53 suboptimal adherence 53 arthralgias 53 EDSS scores 53 neurologic dysfunction 53 cEVR 53 genital ulcers 53 Mg Uk 53 renal flares 53 erosive gastritis 53 mm Hg systolic 53 angina chest 53 Advanced Melanoma 53 Zoledronic Acid 53 ddI 53 cardiovascular ischemic 53 rosuvastatin Crestor 53 serum creatinine levels 53 unstable angina pectoris 53 IgA deficiency 53 Generalized anxiety disorder 53 mcg linaclotide 53 Lupuzor TM 53 Hb A1C 53 Natalizumab 53 Hemoglobin A1c 53 Relapsing Remitting Multiple Sclerosis 53 Pulmonary embolism 53 Dengue Hemorrhagic Fever 53 hypercholesterolaemia 53 ARIXTRA 53 diabetic kidney 53 sulfonylurea metformin 53 Thrombotic 53 nonhematologic adverse reactions 53 Tiotropium 53 VYTORIN ezetimibe simvastatin 53 hypovitaminosis D 53 diarrhea nausea abdominal pain 53 severe rotavirus gastroenteritis 53 Decitabine 53 ischemic cerebrovascular 53 glatiramer 53 primary generalized tonic 53 abdominal pain flatulence 53 REMICADE monotherapy 53 pramlintide 53 hepatitis C genotype 53 ruboxistaurin 53 OGTT 53 RSV infections 53 AGILECT ® 53 BENCHMRK 53 relapsed CLL 53 nonvertebral fracture 53 ZIAGEN 53 paroxetine Paxil 53 headache nasopharyngitis 53 elevated LDL cholesterol 53 Double Blind Randomized 53 fluticasone propionate FP 53 Receptor Antagonists 53 cervicitis 53 reduce serum phosphate 53 symptom exacerbation 53 ACTOplus met 53 MYH9 gene 53 PEGylated interferon beta 1a 53 underwent CABG 53 oral hypoglycemic agent 53 poor metabolizers 53 receiving VELCADE 53 confidence interval #.#-#.# 53 Thalomid ® 53 preserved systolic 53 eosinophilic asthma 53 Lactic acidosis 53 myocardial infarction MI 53 HbA1C levels 53 pancytopenia 53 GW# [003] 53 thromboembolic complications 53 cases/# 53 myalgia arthralgia 53 triglyceride concentration 53 lacunar 53 adverse reactions ≥ 52 MAXALT 52 invasive Hib 52 Hycamtin ® 52 PRADAXA 52 Chronic Constipation 52 hemoglobin A1c HbA1c 52 syncopal episodes 52 AMEVIVE 52 receiving VICTRELIS 52 subclinical hypothyroidism 52 postoperative mortality 52 IOP lowering 52 conventional antipsychotics 52 HCV RESPOND 2 52 Victoza R 52 glycosylated hemoglobin HbA1c 52 pyridostigmine 52 mmol l 52 myocardial infarctions MIs 52 R adefovir dipivoxil 52 induce orthostatic hypotension 52 nocturnal awakenings 52 non hematological toxicities 52 antimuscarinic 52 rufinamide 52 Stomatitis 52 invasive fungal infection 52 pyelonephritis 52 anticholinergic medication 52 leukotriene receptor antagonists 52 pulmonary embolus 52 vaccinees 52 Juvenile Idiopathic Arthritis 52 interferon alfa 2b 52 cardioembolic stroke 52 treatment emergent AEs 52 psoriatic arthritis PsA 52 neutrophil counts 52 exacerbations 52 #.#mmol L [002] 52 PGTC seizures 52 T1DM 52 elevated uric acid 52 inhaled budesonide 52 Avandia Actos 52 Prediabetes 52 Index CDAI 52 Controlled Trial 52 primary hypercholesterolemia 52 immune thrombocytopenic purpura ITP 52 RISPERDAL ® 52 DAS# CRP 52 Ischemic 52 lupus anticoagulant 52 Myocardial infarction 52 venous thromboembolisms 52 baseline A1C 52 decompensation 52 venous thrombosis 52 INRs 52 terlipressin 52 EFFEXOR XR 52 VARIVAX 52 revascularizations 52 cholinesterase inhibitor 52 ADH1B * 52 AGILECT R 52 amoxicillin clavulanate 52 Hyponatremia 52 morphometric vertebral fractures 52 median survivals 52 benazepril 52 Bloodstream infections 52 acute rhinosinusitis 52 ischemic cardiovascular 52 fluticasone salmeterol 52 GERD symptom 52 amenorrhoea 52 status asthmaticus 52 nonfatal stroke 52 rFVIIa 52 somnolence headache 52 zoledronate 52 Neutropenia 52 ketoacidosis hyperosmolar coma 52 ANCA associated 52 anemia leukopenia 52 RSV infects 52 monoclonal gammopathy 52 discontinuations 52 SPRYCEL ® 52 Generalized Anxiety Disorder 52 desvenlafaxine succinate 52 lamivudine monotherapy 52 NYHA Class II 52 sulphonylureas 52 secondary hyperparathyroidism SHPT 52 nausea somnolence 52 abacavir 52 pCR 52 rosuvastatin #mg 52 bacteraemia 52 AVONEX ® 52 sustained ventricular tachycardia 52 progressive neurodegenerative disorder 52 pg ml 52 severe asthma exacerbations 52 lupus erythematosus 52 neutropenia anemia 52 Hashimoto thyroiditis 52 acute rheumatic fever 52 fasting plasma glucose FPG 52 Dermatologic toxicities 52 placebo p 52 LAMICTAL 52 Non Responders 52 dose cohort 52 mcg kg REBETOL 52 Thromboembolic 52 serum phosphate 52 mcg QD 52 WNV encephalitis 52 lipid parameters 52 Xeloda monotherapy 52 FAME Study 52 Peg riba 52 INVEGA ® 52 metastatic malignant 52 RLS symptoms 52 methimazole 52 Severe hypoglycemia 52 Severe hypersensitivity reactions 52 Clinically significant 52 Peripheral neuropathy 52 hyperlipidaemia 52 Asymptomatic 52 prucalopride 52 gestational diabetes mellitus GDM 52 Cholinesterase Inhibitors 52 autonomic dysfunction 52 balsalazide 52 superficial edema 52 ertapenem 52 mycophenolate mofetil 52 arthralgia 52 aminotransferases 52 lenalidomide dexamethasone 52 de aths 52 #mg/dL [001] 52 Proteinuria 52 schizophreniform disorder 52 Schizophrenia affects 52 Serious ocular 52 PASI scores 52 brivaracetam 52 cerebrovascular adverse 52 subarachnoid hemorrhages 52 renal toxicity 52 serum HCV RNA 52 nortriptyline Pamelor 52 smoldering myeloma 52 intravenous bisphosphonates 52 homozygotes 52 bile acid sequestrant 52 MGUS 52 neurodevelopmental impairment 52 tacrolimus ointment 52 nocturnal hypoglycaemia 52 tamoxifen Nolvadex ® 52 GSK# [001] 52 aspartate aminotransferase 52 creatine kinase CK 52 LANTUS ® 52 ischemic complications 52 shorter telomere length 52 aldosterone antagonist 52 paralytic polio 52 hepatic adverse 52 MELAS 52 nonsevere 52 ACTOplus met XR 52 rimonabant #mg 52 serum calcium levels 52 Major Depressive Disorder MDD 52 venous thromboembolic disease 52 cytopenias 52 Bronchiectasis 52 Panic Disorder 52 Prophylactic Treatment 52 cabazitaxel 52 PREZISTA r 52 Anticonvulsants 52 androgen suppression 52 oxygen desaturation 52 mL/min/#.# m2 52 Herpes Simplex Virus 52 Naive Patients 52 Diabetic nephropathy 52 HbA1c levels 52 Catapres 52 paroxysmal AF 52 peripheral edema 52 sotalol 52 plus aztreonam 52 NYHA Class III 52 unprovoked seizures 52 recurrent myocardial infarction 52 sitaxsentan 52 oral antidiabetic drugs 52 torsades de pointes 52 K#N 52 TAXUS p value 52 thyrotropin levels 52 pulmonary exacerbations 51 Follicular Lymphoma 51 stroke transient ischemic 51 nausea dizziness vomiting 51 antiemetics 51 erythematosus 51 nonvertebral 51 Doxepin 51 MACCE 51 lipid lowering agents 51 Pooled Analysis 51 hyperammonemia 51 hyperkalemia 51 MetS 51 IGFBP 51 dysglycemia 51 urge urinary incontinence 51 cardiovascular hospitalization 51 headache chills 51 rhinorrhea 51 PONV 51 undetectable hepatitis C 51 angiotensin converting enzyme inhibitors 51 progressive dyspnea 51 ACTEMRA TM 51 AML MDS 51 Liver Failure 51 pericardial effusion 51 Exacerbation 51 acute bipolar mania 51 angioedema 51 paroxetine sertraline 51 hypervolemic hyponatremia 51 Glipizide 51 mild renal impairment 51 alpha interferons 51 coinfection 51 valsartan amlodipine 51 hysterectomies performed 51 Lantus insulin 51 Acute Renal Failure 51 receiving PEGINTRON 51 C. difficile colitis 51 Restless Legs Syndrome RLS 51 elevated triglycerides 51 coinfected patients 51 Patients Receiving 51 generalized anxiety disorder GAD 51 DEB# 51 Chronic HCV 51 liver transaminases 51 insulin secretagogue 51 Diabetes mellitus 51 PEG IFN 51 TMP SMX 51 ICD shocks 51 neuropsychiatric symptoms 51 Lotensin 51 MULTAQ 51 endometriosis ovarian cysts 51 lower extremity amputations 51 dengue hemorrhagic fever DHF 51 ticlopidine 51 diverticular bleeding 51 Non inferiority 51 Chemotherapy induced 51 hyperphenylalaninemia HPA due 51 fatal myocardial infarction 51 Anti TNF 51 CDI recurrence 51 nociceptive pain 51 clinically meaningful reductions 51 plus methotrexate 51 subcutaneous insulin 51 dermatologic reactions 51 elevated transaminases 51 Fingolimod 51 nausea vomiting cramps 51 systolic BP 51 nonfatal myocardial infarction MI 51 NATRECOR ® 51 mucosal inflammation 51 Orthostatic Hypotension 51 primidone 51 anaphylactoid reactions 51 colorectal adenomas 51 nasopharyngitis headache 51 liver transplantations 51 renal impairment 51 statistical significance p 51 receiving CIMZIA #mg 51 GLIADEL R Wafer 51 Syncope 51 intracranial hemorrhage ICH 51 nondiabetics 51 intracerebral hemorrhage 51 pruritus rash 51 KCNH2 51 binary restenosis 51 nicardipine 51 stent thromboses 51 STN stimulation 51 Acute Pancreatitis 51 See CLINICAL PHARMACOLOGY 51 esophagus bladder 51 symptom flare ups 51 chronic GVHD 51 stable angina 51 Acidosis 51 bronchial hyperresponsiveness 51 Contraindications 51 CLINICAL STUDIES 51 thyroiditis 51 intermittent claudication 51 impaired fasting glucose 51 recurrent DVT 51 Limb Ischemia 51 Fungal Infections 51 divalproex 51 thromboembolism 51 elotuzumab 51 oxycodone IR 51 PEG INTRON 51 thrombocytosis 51 Acute Bacterial Sinusitis ABS 51 onset atrial fibrillation 51 efalizumab 51 Pneumococcal pneumonia 51 spinocerebellar ataxia 51 Nocturia 51 nonischemic 51 hepatic cirrhosis 51 diarrhea vomiting rash 51 symptomatic VTE 51 tardive dyskinesia TD 51 ketoconazole 51 post thrombotic syndrome 51 H. influenzae 51 antiplatelet medications 51 teriflunomide 51 eplerenone 51 comorbid depression 51 nonmelanoma skin cancers 51 Prehypertension 51 PRISTIQ 51 zonisamide SR 51 systolic hypertension 51 Cimzia TM 51 fluvastatin Lescol 51 postintervention 51 typical antipsychotics 51 chlamydial infections 51 proximal DVT 51 PLX STROKE targeting 51 Inflammatory Markers 51 Enlarged prostate 51 glipizide 51 Cholesterol Lowering Drug 51 glucose tolerance test 51 insulin resistance syndrome 51 debilitating autoimmune 51 profuse watery diarrhea 51 % AST SGOT 51 dysmenorrhoea 51 colorectal adenoma 51 myalgia 51 T1c 51 BENICAR HCT 51 aldosterone antagonists 51 febrile seizure 51 aspirin clopidogrel 51 overt hypothyroidism 51 ribavirin USP 51 Hospitalizations 51 MIRAPEX 51 gonadotropin releasing hormone 51 diabetes mellitus 51 D#N 51 symptomatic intracranial 51 Triptan 51 contrast induced nephropathy 51 oral antidiabetes 51 Ascites 51 glatiramer acetate 51 mCRC acneform rash 51 pulmonary dysfunction 51 fulminant hepatitis 51 cerebral infarction 51 myocardial infarction stroke 51 Lantus R 51 mucocutaneous reactions 51 breast endometrial 51 Herpes zoster 51 lactic acidosis 50 oral diclofenac 50 P. falciparum malaria 50 PENTASA 50 bacterium Neisseria meningitidis 50 Gestational diabetes 50 amenorrhea 50 unknown etiology 50 urethritis 50 idiopathic PAH 50 tachyarrhythmias 50 somnolence sedation 50 ARICEPT 50 Main Outcome Measure 50 stomach cramps nausea vomiting 50 divalproex sodium 50 asymptomatic PAD 50 tapentadol ER 50 Tardive Dyskinesia 50 LEXIVA 50 Diabetic Neuropathy 50 Renal impairment 50 adrenal suppression 50 Major Depressive 50 placebo controlled clinical trials 50 akathisia 50 gastrointestinal reflux 50 ACR# ACR# 50 Mucositis 50 omeprazole Prilosec 50 immunomodulatory therapy 50 #mg/day [001] 50 relapsing remitting 50 Monopril 50 See WARNINGS 50 acid regurgitation 50 benign prostatic hypertrophy BPH 50 QTc prolongation 50 anaphylactic episodes 50 euthyroid 50 hallucinations dyskinesia 50 Celiac disease affects 50 VaD 50 HCV Genotype 50 ischemia driven 50 Combination Treatment 50 Diabetes Mellitus 50 Nesiritide 50 dermatologic toxicities 50 serum triglycerides 50 diastolic hypertension 50 Clinical Practice Guideline 50 Ejection Fraction 50 Significantly Reduced 50 chronic renal insufficiency 50 URG# targets 50 events MACE 50 serious Interstitial Lung 50 anthracycline containing 50 Hyperkalemia 50 ECG abnormalities 50 Myelofibrosis 50 Acute myeloid leukemia 50 fatigue asthenia 50 hypoglycaemia 50 recurrent ischemic 50 Hypoglycaemia 50 decompensated heart failure 50 non valvular atrial 50 GnRH agonists 50 obstructive apnea 50 serum retinol 50 mean baseline A1C 50 NovoSeven ® 50 AA Amyloidosis 50 Ankylosing spondylitis 50 Ranolazine 50 Avanafil 50 GERD symptoms 50 diabetic dyslipidemia 50 CLINICAL PHARMACOLOGY 50 periprocedural 50 recurrent ischemia 50 HOMA IR 50 CHD mortality 50 LV dysfunction 50 incidence ≥ 50 BUPHENYL 50 paresthesias 50 6R BH4 50 hypoglycemia 50 complement inhibitor eculizumab 50 mU liter 50 beta blockers ACE inhibitors 50 Treated Patients 50 transient ischemic 50 CAMMS# 50 abdominal distension 50 undergone radical prostatectomy 50 CYP#C# * 50 CKD Stage 50 hypertension dyslipidemia 50 somatostatin analog 50 Anxiety disorders 50 Glatiramer Acetate 50 Drug Prevents 50 gallbladder disease 50 rebleeding 50 Platinol ® 50 del 5q 50 febrile illness 50 Hyperlipidemia 50 optic neuropathy 50 aripiprazole 50 serum urate levels 50 Rheumatoid arthritis affects 50 GG genotype 50 cystic fibrosis chronic pancreatitis 50 acute respiratory tract infections 50 chronic rhinosinusitis 50 rotavirus gastroenteritis 50 tolterodine 50 prospectively stratified 50 Genital Herpes 50 angiotensin II receptor blockers 50 selective modulator 50 hemoptysis 50 hemolytic uremic syndrome HUS 50 mmol L 50 MMRV vaccine 50 coronary stenosis 50 Comorbid 50 radicular pain 50 Thiazolidinediones 50 abdominal adiposity 50 Partial Response 50 Rheumatoid Arthritis Patients 50 tranylcypromine 50 microvascular complications